Saranac Partners Ltd

Position in BMY — Bristol Myers Squibb Co

CIK 2098745 LONDON, X0

Position in BMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$421,259

-$14,268 QoQ

Shares Held

7,311

+1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#1,634

of 2,506 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names. BMY ranks #5 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	41,086	$10,338,881
2	AZN	Astrazeneca PLC	4,522	$857,461
3	LLY	ELI LILLY & Co	487	$584,122
4	NVO	Novo Nordisk A S	11,090	$531,654
5	BMY	Bristol Myers Squibb Co This page	7,311	$421,259
6	JNJ	Johnson & Johnson	1,612	$409,399

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$421,259	7,311	+1.8%	Shares	Sole	2026-08-13
2026-03-31	$435,527	7,181	+5.5%	Shares	Sole	2026-05-15
2025-12-31	$367,115	6,806	+6.7%	Shares	Sole	2026-02-06
2025-09-30	$287,778	6,381	+32.1%	Shares	Sole	2025-12-05
2025-06-30	$223,580	4,830	-15.3%	Shares	Sole	2025-12-15
2025-03-31	$347,703	5,701	+15.7%	Shares	Sole	2025-12-15
2024-12-31	$278,614	4,926	-18.0%	Shares	Sole	2026-02-02
2024-09-30	$310,802	6,007	+0.8%	Shares	Sole	2026-02-02
2024-06-30	$247,601	5,962	0.0%	Shares	Sole	2026-02-02
2024-03-31	$323,319	5,962	+10.8%	Shares	Sole	2026-02-02
2023-12-31	$276,150	5,382	0.0%	Shares	Sole	2026-02-02
2023-09-30	$312,371	5,382	0.0%	Shares	Sole	2026-02-02
2023-06-30	$344,178	5,382	0.0%	Shares	Sole	2026-02-06
2023-03-31	$373,026	5,382	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.